
Spectra Therapeutics Private Limited
About Spectra Therapeutics Private Limited
Data last updated:
Spectra Therapeutics Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51101GJ2013PTC073997. Its GSTIN is 24AASCS8135P1ZH (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kiran Amratlal Joshi and Rakesh Vasudev Thakar.
Its last annual general meeting (AGM) was held on 04 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.02 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹82.63 Lakh (net margin 2.2%) and EBITDA of ₹97.92 Lakh (EBITDA margin 2.6%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 20% over five years.
The company has about 42 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹53 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Spectra Therapeutics Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address502 Fortune Business Hub, Near Satyamev Elysiym, Ahmedabad, Gujarat, India – 380060
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Spectra Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Spectra Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Spectra Therapeutics Private Limited, buy the company report.
Financials of Spectra Therapeutics Private Limited
FY 2025 filings availableSpectra Therapeutics Private Limited reported revenue of ₹37.02 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 20% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹97.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹82.63 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spectra Therapeutics Private Limited, buy the company report.
Board of directors of Spectra Therapeutics Private Limited
Spectra Therapeutics has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kiran Amratlal Joshi | Director | 15 Mar 2013 | 13 Years 7 Months | Current |
| Rakesh Vasudev Thakar | Director | 15 Mar 2013 | 13 Years 7 Months | Current |
| Dharmeshkumar Hemshankar Thaker | Director | 15 Mar 2013 | 13 Years 7 Months | Current |
Peer comparison
Spectra Therapeutics Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medi Basket Private Limited | ₹37.39 Cr (FY 2024) | 115.0% | Indore, Madhya Pradesh, India | |||
| Spectra Therapeutics Private Limitedthis company | ₹37.02 Cr (FY 2025) | ₹82.63 Lakh | 2.2% | 20.0% | 42 | Ahmedabad, Gujarat, India |
| Nexnos Pharma Limited | ₹36.91 Cr (FY 2025) | 187.0% | Chittorgarh, Rajasthan, India | |||
| H Jules & Company Ltd | ₹36.88 Cr (FY 2023) | 19.0% | Nagpur, Maharashtra, India | |||
| Biotech Solutions & Pharmaceuticals Limited | ₹36.57 Cr (FY 2024) | 23.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Spectra Therapeutics Private Limited, buy the company report.
Auditor
Spectra Therapeutics Private Limited is audited by ARPITKUMAR & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARPITKUMAR & ASSOCIATES | FY 2022 | 155095W |
Shareholding
The shareholding of Spectra Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Spectra Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Jul 2019 | 100279053 | Others | ₹53 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Spectra Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spectra Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Spectra Therapeutics Private Limited has a workforce of 42 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
GST
Spectra Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AASCS8135P1ZH | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Spectra Therapeutics Private Limited, buy the company report.
Recent activity
Spectra Therapeutics Private Limited has 3 board changes on record since 2013: 3 appointments. The latest: Dharmeshkumar Hemshankar Thaker was appointed as Director on 15 Mar 2013.
Frequently asked questions
Spectra Therapeutics is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 March 2013 (13+ years old) and is registered under CIN U51101GJ2013PTC073997.
Spectra Therapeutics has 3 current directors:
- Kiran Amratlal Joshi - Director
- Rakesh Vasudev Thakar - Director
- Dharmeshkumar Hemshankar Thaker - Director
The latest financial statements of Spectra Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 04 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Spectra Therapeutics is 24AASCS8135P1ZH, registered in Gujarat.
The CIN (Corporate Identification Number) of Spectra Therapeutics is U51101GJ2013PTC073997. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spectra Therapeutics was incorporated on 15 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Spectra Therapeutics by revenue are Medi Basket Private Limited, Nexnos Pharma Limited, H Jules & Company Ltd, Biotech Solutions & Pharmaceuticals Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Dharmeshkumar Hemshankar Thaker was appointed as Director on 15 Mar 2013. Kiran Amratlal Joshi was appointed as Director on 15 Mar 2013. Rakesh Vasudev Thakar was appointed as Director on 15 Mar 2013.
The registered office of Spectra Therapeutics is at 502 Fortune Business Hub, Near Satyamev Elysiym, Ahmedabad, Gujarat, India – 380060.
Spectra Therapeutics operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Spectra Therapeutics has open charges of ₹53 Lakh and no satisfied charges on record as per latest MCA filings.

